MITA Applauds FDA Leqembi Traditional Approval

The Medical Imaging & Technology Alliance (MITA) supports the U.S.FDA’s approval of Leqembi for mild cognitive impairment or mild dementia but urges the Centers for Medicare & Medicaid Services to reconsider the one scan limit and remove the coverage with evidence development policy for beta-amyloid PET.